Johnson & Johnson Stock Has Surged 44%, Can Its Growth Justify the Valuation?

Johnson & Johnson (NYSE:JNJ) is no longer trading like a stock that investors have simply overlooked. The shares closed at $264.74 on September 30, considerably up from $185.42 a year earlier, or around 41.66%. Over the same period, the S&P 500 gained about 14.41%. There are nine healthcare stocks other than JNJ in our ranking […]